Retinal AI Predicts Neonatal Lung Disease - Scorecard - MDSpire

Retinal AI Predicts Neonatal Lung Disease

  • By

  • Conexiant News Staff

  • February 17, 2026

  • 4 min

Share

Clinical Scorecard: Retinal AI Predicts Neonatal Lung Disease

At a Glance

CategoryDetail
ConditionBronchopulmonary Dysplasia and Pulmonary Hypertension in Premature Infants
Key MechanismsDeep learning models analyzing retinal images to predict cardiopulmonary disease.
Target PopulationPremature infants, particularly those screened for retinopathy of prematurity.
Care SettingNeonatal Intensive Care Units (NICUs)

Key Highlights

  • Deep learning models can predict bronchopulmonary dysplasia and pulmonary hypertension from retinal images.
  • Multimodal models combining imaging and demographic data outperformed single-modality models.
  • The study utilized data from the i-ROP study, focusing on infants at 34 weeks' postmenstrual age or less.

Guideline-Based Recommendations

Diagnosis

  • Use retinal imaging as a predictive tool for bronchopulmonary dysplasia and pulmonary hypertension.

Management

  • Consider integrating retinal imaging into routine screening protocols for at-risk infants.

Monitoring & Follow-up

  • Monitor infants with abnormal retinal findings for potential cardiopulmonary complications.

Risks

  • Be aware of limitations in model performance across different imaging devices and settings.

Patient & Prescribing Data

Infants enrolled in the i-ROP study, particularly those with gestational age and birth weight data.

Retinal imaging may provide a non-invasive method to identify infants at risk for severe lung disease.

Clinical Best Practices

  • Incorporate retinal imaging into standard care for premature infants.
  • Utilize multimodal predictive models for better diagnostic accuracy.

References

Original Source(s)

Related Content